|
|
Article: Pharmaceutical Firm ARTEC, Inc.(TM) Announces Production of TUBERCIN(TM) for Selected Uses in South Africa and the Bahamas - Shareholders Follow-Up Report.
- Article from:
- Business Wire
- Article date:
- November 26, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
OKLAHOMA CITY -- Production of TUBERCIN[TM], a revolutionary polysaccharide compound to be used as an HIV/AIDS and ANTI-CANCER immunostimulant, has begun with the focus on South Africa and the Bahamas as mission delivery sites, announces Mr. Gerry Knight, Executive Vice President of ARTEC, Inc.[TM] (Pink Sheets:ATKJ). ARTEC, Inc.[TM] has recently received the final plan for the testing on HIV/AIDS and Tuberculosis Patients in South Africa and anticipates in starting the testing process in early 2008.
Mr. Rodney Watson, ARTEC, Inc.[TM] South African Coordinator, is working on the details and logistics. More detailed information will be made available in future ...
Related newspaper, magazine, and journal articles:
|
|
Article: NetApp Certifies ARTEC E-Mail Archiving Appliances.
Business Wire;
March 8, 2007 ;
700+ words
... ... before a specified retention date. ARTEC EMA appliances empower customers to ... and archiving challenge." About ARTEC ARTEC Computer GmbH specializes in providing ... Information about Network Appliance[TM] solutions and services is available ...
|
|